Nifty
Sensex
:
:
25637.80
84058.90
88.80 (0.35%)
303.03 (0.36%)

Pharmaceuticals & Drugs - Global

Rating :
68/99

BSE: 500420 | NSE: TORNTPHARM

3341.40
27-Jun-2025
  • Open
  • High
  • Low
  • Previous Close
  •  3350
  •  3377
  •  3287
  •  3222.50
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  1739609
  •  5789394699.3
  •  3590.7
  •  2757.9

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,13,189.69
  • 59.23
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,15,636.69
  • 0.96%
  • 14.91

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 68.31%
  • 0.39%
  • 4.51%
  • FII
  • DII
  • Others
  • 16.31%
  • 6.44%
  • 4.04%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.71
  • 6.21
  • 8.03

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 12.67
  • 9.16
  • 6.71

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.23
  • 10.08
  • 28.69

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 50.55
  • 55.05
  • 60.42

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 8.57
  • 10.15
  • 11.53

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 21.38
  • 23.83
  • 26.09

Earnings Forecasts:

(Updated: 06-06-2025)
Description
2024
2025
2026
2027
Adj EPS
48.94
56.47
73.5
89.06
P/E Ratio
68.28
59.17
45.46
37.52
Revenue
10562
11317
12965
14533
EBITDA
3368
3721
4290
4911
Net Income
1656
1911
2487
3010
ROA
11
12.7
17.8
19.6
P/B Ratio
16.56
14.90
12.51
10.39
ROE
25.38
26.46
29.63
30.09
FCFF
2475
1732
2940
3151
FCFF Yield
2.26
1.58
2.68
2.87
Net Debt
3059
2511
1287
23
BVPS
201.77
224.3
267.11
321.53

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Net Sales
2,959.00
2,745.00
7.80%
2,809.00
2,732.00
2.82%
2,889.00
2,660.00
8.61%
2,859.00
2,591.00
10.34%
Expenses
1,995.00
1,862.00
7.14%
1,895.00
1,863.00
1.72%
1,950.00
1,835.00
6.27%
1,955.00
1,800.00
8.61%
EBITDA
964.00
883.00
9.17%
914.00
869.00
5.18%
939.00
825.00
13.82%
904.00
791.00
14.29%
EBIDTM
32.58%
32.17%
32.54%
31.81%
32.50%
31.02%
31.62%
30.53%
Other Income
-18.00
31.00
-
33.00
-33.00
-
-16.00
26.00
-
24.00
34.00
-29.41%
Interest
56.00
80.00
-30.00%
57.00
80.00
-28.75%
64.00
91.00
-29.67%
75.00
103.00
-27.18%
Depreciation
201.00
203.00
-0.99%
199.00
213.00
-6.57%
198.00
201.00
-1.49%
197.00
191.00
3.14%
PBT
665.00
631.00
5.39%
691.00
631.00
9.51%
661.00
559.00
18.25%
656.00
531.00
23.54%
Tax
167.00
182.00
-8.24%
188.00
188.00
0.00%
208.00
173.00
20.23%
199.00
153.00
30.07%
PAT
498.00
449.00
10.91%
503.00
443.00
13.54%
453.00
386.00
17.36%
457.00
378.00
20.90%
PATM
16.83%
16.36%
17.91%
16.22%
15.68%
14.51%
15.98%
14.59%
EPS
14.71
13.27
10.85%
14.86
13.09
13.52%
13.38
11.40
17.37%
13.50
11.17
20.86%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
11,516.00
10,727.84
9,620.15
8,508.04
8,004.57
7,939.31
7,672.80
5,949.83
5,815.69
6,666.85
4,653.45
Net Sales Growth
7.35%
11.51%
13.07%
6.29%
0.82%
3.47%
28.96%
2.31%
-12.77%
43.27%
 
Cost Of Goods Sold
2,776.00
2,458.95
2,513.20
2,230.75
1,960.12
1,981.79
2,041.26
1,535.17
1,629.66
1,432.13
1,280.96
Gross Profit
8,740.00
8,268.89
7,106.95
6,277.29
6,044.45
5,957.52
5,631.54
4,414.66
4,186.03
5,234.72
3,372.49
GP Margin
75.89%
77.08%
73.88%
73.78%
75.51%
75.04%
73.40%
74.20%
71.98%
78.52%
72.47%
Total Expenditure
7,795.00
7,364.25
6,796.18
6,076.77
5,524.49
5,768.95
5,696.31
4,600.58
4,438.42
3,937.05
3,633.29
Power & Fuel Cost
-
145.20
155.28
144.19
122.94
128.19
132.46
118.77
107.98
92.59
97.41
% Of Sales
-
1.35%
1.61%
1.69%
1.54%
1.61%
1.73%
2.00%
1.86%
1.39%
2.09%
Employee Cost
-
1,984.40
1,677.69
1,526.45
1,439.62
1,429.04
1,403.79
1,135.25
993.41
842.35
841.81
% Of Sales
-
18.50%
17.44%
17.94%
17.98%
18.00%
18.30%
19.08%
17.08%
12.63%
18.09%
Manufacturing Exp.
-
570.58
570.79
591.13
550.92
544.11
558.84
457.58
502.16
353.45
345.98
% Of Sales
-
5.32%
5.93%
6.95%
6.88%
6.85%
7.28%
7.69%
8.63%
5.30%
7.43%
General & Admin Exp.
-
980.72
775.30
637.65
633.48
801.98
763.90
677.71
578.05
637.92
463.28
% Of Sales
-
9.14%
8.06%
7.49%
7.91%
10.10%
9.96%
11.39%
9.94%
9.57%
9.96%
Selling & Distn. Exp.
-
1,129.68
1,026.99
884.91
742.63
807.39
738.03
641.30
567.70
547.05
574.40
% Of Sales
-
10.53%
10.68%
10.40%
9.28%
10.17%
9.62%
10.78%
9.76%
8.21%
12.34%
Miscellaneous Exp.
-
94.72
76.93
61.69
74.78
76.45
58.03
34.80
59.46
31.56
574.40
% Of Sales
-
0.88%
0.80%
0.73%
0.93%
0.96%
0.76%
0.58%
1.02%
0.47%
0.63%
EBITDA
3,721.00
3,363.59
2,823.97
2,431.27
2,480.08
2,170.36
1,976.49
1,349.25
1,377.27
2,729.80
1,020.16
EBITDA Margin
32.31%
31.35%
29.35%
28.58%
30.98%
27.34%
25.76%
22.68%
23.68%
40.95%
21.92%
Other Income
23.00
61.97
63.22
196.56
56.91
121.30
63.62
298.84
223.30
228.80
285.55
Interest
252.00
353.56
333.44
255.06
352.94
450.71
503.75
308.48
205.56
183.98
175.16
Depreciation
795.00
808.27
706.59
662.16
657.79
654.38
617.69
408.60
306.92
237.55
190.74
PBT
2,673.00
2,263.73
1,847.16
1,710.61
1,526.26
1,186.57
918.67
931.01
1,088.09
2,537.07
939.81
Tax
762.00
695.73
601.93
448.73
274.38
161.85
125.35
252.87
154.51
610.17
188.84
Tax Rate
28.51%
29.58%
32.59%
36.60%
17.98%
13.64%
22.32%
27.16%
14.20%
26.04%
20.09%
PAT
1,911.00
1,656.38
1,245.23
777.18
1,251.88
1,024.72
436.28
678.11
933.55
1,733.24
750.94
PAT before Minority Interest
1,911.00
1,656.38
1,245.23
777.18
1,251.88
1,024.72
436.31
678.14
933.58
1,733.27
750.97
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
-0.03
-0.03
-0.03
-0.03
-0.03
PAT Margin
16.59%
15.44%
12.94%
9.13%
15.64%
12.91%
5.69%
11.40%
16.05%
26.00%
16.14%
PAT Growth
15.40%
33.02%
60.22%
-37.92%
22.17%
134.88%
-35.66%
-27.36%
-46.14%
130.81%
 
EPS
56.47
48.95
36.80
22.97
36.99
30.28
12.89
20.04
27.59
51.22
22.19

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
6,856.15
6,198.07
5,952.95
5,837.17
4,823.22
4,724.35
4,622.19
4,350.13
3,494.10
2,490.56
Share Capital
169.23
169.23
84.62
84.62
84.62
84.62
84.62
84.62
84.62
84.62
Total Reserves
6,686.92
6,028.84
5,868.33
5,752.55
4,738.60
4,639.73
4,537.57
4,265.51
3,409.48
2,405.94
Non-Current Liabilities
2,224.05
2,822.81
2,238.15
2,924.20
3,299.15
3,861.40
4,142.42
2,303.33
1,994.65
2,504.92
Secured Loans
1,603.78
2,496.22
2,123.22
2,941.07
3,302.29
3,909.81
4,105.31
2,229.57
1,839.46
2,171.60
Unsecured Loans
0.00
0.00
0.00
0.00
1.56
3.11
6.15
11.26
10.62
13.62
Long Term Provisions
444.69
393.06
368.74
369.62
338.34
288.52
286.66
263.04
246.36
207.49
Current Liabilities
5,425.25
5,447.30
4,415.09
4,891.62
5,454.16
5,165.32
5,202.17
2,738.26
3,285.48
2,823.75
Trade Payables
2,089.32
1,678.80
1,674.44
2,066.81
2,048.81
2,096.74
2,048.24
1,749.32
2,260.22
1,827.72
Other Current Liabilities
1,130.15
1,578.41
1,365.10
1,635.36
1,860.80
1,641.26
1,151.68
687.14
822.28
446.15
Short Term Borrowings
1,637.71
1,765.07
923.04
704.40
1,090.85
934.11
1,625.60
0.00
3.32
319.07
Short Term Provisions
568.07
425.02
452.51
485.05
453.70
493.21
376.65
301.80
199.66
230.81
Total Liabilities
14,505.45
14,468.18
12,606.19
13,652.99
13,576.53
13,751.07
13,967.30
9,392.21
8,774.69
7,819.66
Net Block
8,138.11
8,121.45
6,422.65
7,064.63
7,533.12
7,747.71
7,854.68
3,688.44
2,859.08
2,832.66
Gross Block
13,484.57
12,811.62
10,728.19
10,511.53
10,334.13
9,935.43
9,449.48
4,909.80
3,793.53
3,542.93
Accumulated Depreciation
5,346.46
4,690.17
4,305.54
3,446.90
2,801.01
2,187.72
1,594.80
1,221.36
934.45
710.27
Non Current Assets
8,893.97
9,139.00
7,311.54
8,129.77
8,595.61
8,713.53
8,704.89
4,512.74
4,085.66
3,768.25
Capital Work in Progress
360.51
765.40
629.82
889.38
711.93
617.12
646.94
519.49
1,041.58
678.33
Non Current Investment
31.80
42.70
42.33
42.09
2.09
2.09
0.09
0.09
0.09
0.06
Long Term Loans & Adv.
349.34
181.04
166.55
96.84
222.19
150.58
130.96
182.32
99.66
206.92
Other Non Current Assets
14.21
28.41
50.19
36.83
126.28
196.03
72.22
122.40
85.25
50.28
Current Assets
5,611.48
5,313.72
5,164.99
5,523.22
4,980.92
5,037.54
5,262.41
4,879.47
4,689.03
4,051.41
Current Investments
141.04
156.09
183.98
139.05
0.02
351.35
492.27
803.55
779.59
297.59
Inventories
2,279.07
2,229.64
2,462.32
2,681.20
2,148.22
1,935.15
1,966.30
1,559.15
1,357.98
1,067.17
Sundry Debtors
1,844.30
1,943.82
1,632.48
1,523.37
1,649.34
1,435.71
1,253.45
950.89
1,445.09
1,587.26
Cash & Bank
839.04
571.46
403.41
603.50
666.65
816.04
867.23
893.72
647.03
567.36
Other Current Assets
508.03
246.89
331.62
512.69
516.69
499.29
683.16
672.16
459.34
532.03
Short Term Loans & Adv.
180.04
165.82
151.18
63.41
73.48
93.46
95.39
82.62
90.18
109.09
Net Current Assets
186.23
-133.58
749.90
631.60
-473.24
-127.78
60.24
2,141.21
1,403.55
1,227.66
Total Assets
14,505.45
14,452.72
12,476.53
13,652.99
13,576.53
13,751.07
13,967.30
9,392.21
8,774.69
7,819.66

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Cash From Operating Activity
3,266.08
2,368.13
1,802.99
2,005.35
1,392.91
1,798.08
894.15
1,008.84
2,742.12
810.20
PBT
2,352.11
1,847.16
1,225.91
1,526.26
1,186.57
561.66
931.01
1,088.09
2,343.44
939.81
Adjustment
993.99
937.24
1,349.95
992.84
876.21
1,418.19
606.92
430.27
552.44
337.96
Changes in Working Capital
418.08
-18.20
-351.85
-338.25
-385.83
99.39
-360.16
-125.21
423.58
-409.38
Cash after chg. in Working capital
3,764.18
2,766.20
2,224.01
2,180.85
1,676.95
2,079.24
1,177.77
1,393.15
3,319.46
868.39
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-498.10
-398.07
-421.02
-175.50
-284.04
-281.16
-283.62
-384.31
-577.34
-58.19
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-167.90
-2,415.31
-196.63
-449.42
198.61
-241.28
-4,706.95
-786.91
-837.85
-2,162.30
Net Fixed Assets
-161.25
-2,494.94
-29.00
-198.83
-378.80
-610.74
-4,245.22
-592.01
-471.42
-2,266.57
Net Investments
-102.10
6.43
-53.72
-179.03
351.33
138.83
310.79
-17.69
-484.32
-111.97
Others
95.45
73.20
-113.91
-71.56
226.08
230.63
-772.52
-177.21
117.89
216.24
Cash from Financing Activity
-2,779.64
77.36
-1,781.05
-1,650.79
-1,549.04
-1,314.45
3,417.39
-192.91
-1,435.15
1,212.25
Net Cash Inflow / Outflow
318.54
30.18
-174.69
-94.86
42.48
242.35
-395.41
29.02
469.12
-139.85
Opening Cash & Equivalents
508.53
398.40
572.56
661.82
588.76
702.04
1,067.57
1,049.86
612.38
955.05
Closing Cash & Equivalent
835.14
508.53
398.40
572.56
661.82
940.06
702.04
1,067.57
1,049.86
864.95

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
202.57
183.13
175.87
172.45
284.99
279.15
273.11
257.04
206.46
147.16
ROA
11.43%
9.20%
5.92%
9.20%
7.50%
3.15%
5.81%
10.28%
20.89%
11.71%
ROE
25.38%
20.50%
13.18%
23.49%
21.47%
9.34%
15.12%
23.80%
57.92%
34.19%
ROCE
24.28%
20.32%
14.35%
17.62%
15.28%
9.75%
13.81%
20.36%
45.63%
26.98%
Fixed Asset Turnover
1.27
1.39
1.43
1.43
1.48
1.50
1.57
1.35
1.82
1.88
Receivable days
41.38
39.99
37.86
38.92
37.65
33.78
35.74
74.66
82.76
105.19
Inventory Days
49.26
52.47
61.71
59.24
49.84
49.01
57.16
90.90
66.19
81.17
Payable days
279.66
243.50
306.08
383.19
133.47
139.05
150.99
171.27
204.35
176.11
Cash Conversion Cycle
-189.03
-151.04
-206.50
-285.04
-45.98
-56.26
-58.09
-5.72
-55.41
10.25
Total Debt/Equity
0.57
0.85
0.68
0.83
1.21
1.28
1.40
0.58
0.67
1.10
Interest Cover
7.65
6.54
5.81
5.32
3.63
2.11
4.02
6.29
13.74
6.37

News Update:


  • Torrent Pharmaceuticals raises Rs 300 crore through Commercial Papers
    27th Jun 2025, 11:30 AM

    Maturity of the said Commercial Papers will be on September 26, 2025

    Read More
  • Torrent Pharmaceuticals raises Rs 200 crore through Commercial Papers
    21st Jun 2025, 11:35 AM

    Tenure of the instrument is 90 days

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.